[go: up one dir, main page]

IT1317922B1 - Metodo per identificare in vivo epitopi intracellulari. - Google Patents

Metodo per identificare in vivo epitopi intracellulari.

Info

Publication number
IT1317922B1
IT1317922B1 IT2000RM000561A ITRM20000561A IT1317922B1 IT 1317922 B1 IT1317922 B1 IT 1317922B1 IT 2000RM000561 A IT2000RM000561 A IT 2000RM000561A IT RM20000561 A ITRM20000561 A IT RM20000561A IT 1317922 B1 IT1317922 B1 IT 1317922B1
Authority
IT
Italy
Prior art keywords
peptide
recognise
molecule
cells
vivo
Prior art date
Application number
IT2000RM000561A
Other languages
English (en)
Inventor
Antonino Cattaneo
Michela Visintin
Original Assignee
S I S S A Scuola Internaz Supe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I S S A Scuola Internaz Supe filed Critical S I S S A Scuola Internaz Supe
Publication of ITRM20000561A0 publication Critical patent/ITRM20000561A0/it
Priority to IT2000RM000561A priority Critical patent/IT1317922B1/it
Priority to DK01983776T priority patent/DK1328814T3/da
Priority to AU2002215194A priority patent/AU2002215194A1/en
Priority to DE60123819T priority patent/DE60123819T2/de
Priority to EP01983776A priority patent/EP1328814B1/en
Priority to CA002426744A priority patent/CA2426744A1/en
Priority to ES01983776T priority patent/ES2272553T3/es
Priority to AT01983776T priority patent/ATE342511T1/de
Priority to SI200130661T priority patent/SI1328814T1/sl
Priority to JP2002538169A priority patent/JP2004512529A/ja
Priority to PCT/IT2001/000535 priority patent/WO2002035237A2/en
Priority to PT01983776T priority patent/PT1328814E/pt
Publication of ITRM20000561A1 publication Critical patent/ITRM20000561A1/it
Priority to US10/418,388 priority patent/US20030235850A1/en
Application granted granted Critical
Publication of IT1317922B1 publication Critical patent/IT1317922B1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IT2000RM000561A 2000-10-24 2000-10-24 Metodo per identificare in vivo epitopi intracellulari. IT1317922B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT2000RM000561A IT1317922B1 (it) 2000-10-24 2000-10-24 Metodo per identificare in vivo epitopi intracellulari.
ES01983776T ES2272553T3 (es) 2000-10-24 2001-10-22 Metodo para identificacion envivo de epitopos intracelulares.
SI200130661T SI1328814T1 (sl) 2000-10-24 2001-10-22 Postopek za in vivo identifikacijo intracelularnih epitopov
DE60123819T DE60123819T2 (de) 2000-10-24 2001-10-22 Methode zur in vivo identifizierung von intrazellularen epitopen
EP01983776A EP1328814B1 (en) 2000-10-24 2001-10-22 Method for in vivo identification of intracellular epitopes
CA002426744A CA2426744A1 (en) 2000-10-24 2001-10-22 Method for in vivo identification of intracellular epitopes
DK01983776T DK1328814T3 (da) 2000-10-24 2001-10-22 Fremgangsmåde til identifikation in vivo af intracellulære epitoper
AT01983776T ATE342511T1 (de) 2000-10-24 2001-10-22 Methode zur in vivo identifizierung von intrazellularen epitopen
AU2002215194A AU2002215194A1 (en) 2000-10-24 2001-10-22 Method for in vivo identification of intracellular epitopes
JP2002538169A JP2004512529A (ja) 2000-10-24 2001-10-22 細胞内エピトープの生体内同定方法
PCT/IT2001/000535 WO2002035237A2 (en) 2000-10-24 2001-10-22 Method for in vivo identification of intracellular epitopes
PT01983776T PT1328814E (pt) 2000-10-24 2001-10-22 Método para identificação in vivo de epítopos intracelulares
US10/418,388 US20030235850A1 (en) 2000-10-24 2003-04-18 Method for in vivo identification of intracellular epitopes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000561A IT1317922B1 (it) 2000-10-24 2000-10-24 Metodo per identificare in vivo epitopi intracellulari.

Publications (3)

Publication Number Publication Date
ITRM20000561A0 ITRM20000561A0 (it) 2000-10-24
ITRM20000561A1 ITRM20000561A1 (it) 2002-04-24
IT1317922B1 true IT1317922B1 (it) 2003-07-15

Family

ID=11454967

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000561A IT1317922B1 (it) 2000-10-24 2000-10-24 Metodo per identificare in vivo epitopi intracellulari.

Country Status (12)

Country Link
US (1) US20030235850A1 (it)
EP (1) EP1328814B1 (it)
JP (1) JP2004512529A (it)
AT (1) ATE342511T1 (it)
AU (1) AU2002215194A1 (it)
CA (1) CA2426744A1 (it)
DE (1) DE60123819T2 (it)
DK (1) DK1328814T3 (it)
ES (1) ES2272553T3 (it)
IT (1) IT1317922B1 (it)
PT (1) PT1328814E (it)
WO (1) WO2002035237A2 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799535B1 (en) 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
DE60224383T3 (de) 2001-02-15 2012-06-28 The University Of Chicago Verfahren zum nachweis in hefe für mittel die proteinfaltung beeinflussen
WO2012162179A1 (en) * 2011-05-20 2012-11-29 Oligomerix, Inc. Tau protease compositions and methods of use
CA2853734A1 (en) * 2011-10-28 2013-05-02 University Of Maryland Methods and compositions related to intracellular neutralization by igg
SG10201800800YA (en) 2013-05-06 2018-03-28 Scholar Rock Inc Compositions and methods for growth factor modulation
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
EP4183806A3 (en) 2014-11-12 2023-08-02 Seagen Inc. Glycan-interacting compounds and methods of use
ITUB20155272A1 (it) 2015-11-02 2017-05-02 Scuola Normale Superiore Intracellular antibody
IL258768B2 (en) 2015-11-12 2023-11-01 Siamab Therapeutics Inc Compounds interacting with glycans and methods of use
US11401330B2 (en) 2016-11-17 2022-08-02 Seagen Inc. Glycan-interacting compounds and methods of use
KR102653141B1 (ko) 2017-03-03 2024-04-01 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
ATE273323T1 (de) * 1999-12-28 2004-08-15 Esbatech Ag INTRAKÖRPER MIT DEFINIERTER STRUKTUR (ßFRAMEWORKß), DIE IN EINER REDUZIERENDEN UMGEBUNG STABIL IST, UND IHRE VERWENDUNGEN

Also Published As

Publication number Publication date
EP1328814B1 (en) 2006-10-11
WO2002035237A3 (en) 2002-10-10
ES2272553T3 (es) 2007-05-01
DK1328814T3 (da) 2007-01-29
CA2426744A1 (en) 2002-05-02
PT1328814E (pt) 2007-01-31
DE60123819T2 (de) 2007-08-02
ITRM20000561A1 (it) 2002-04-24
AU2002215194A1 (en) 2002-05-06
DE60123819D1 (de) 2006-11-23
JP2004512529A (ja) 2004-04-22
ITRM20000561A0 (it) 2000-10-24
WO2002035237A2 (en) 2002-05-02
EP1328814A2 (en) 2003-07-23
ATE342511T1 (de) 2006-11-15
US20030235850A1 (en) 2003-12-25

Similar Documents

Publication Publication Date Title
WO2002020569A3 (en) Mammalian genes; related reagents and methods
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2001032712A3 (en) Antibody diversity generation
ATE290880T1 (de) Antigene zusammensetzung die ein polykationisches peptid und inosin und cytosin enthält
IT1317922B1 (it) Metodo per identificare in vivo epitopi intracellulari.
AU3117201A (en) Methods and compositions for generating human monoclonal antibodies
NO20021992D0 (no) Anti-prostatastamcelleantigen(PSCA)-antistoffpreparat og fremgangsmåter for anvendelse
DK0672063T3 (da) Mindste genkendelsesenhed af et PEM mucintandemgentagelsesspecifikt monoklonalt antistof
IL273648B1 (en) Microbiota sequence variants of tumor-related antigenic epitopes
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
WO1998022510A3 (en) Methods for the production of chicken monoclonal antibodies
IL127595A0 (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus D antigens the DNA encoding them and the process for their preparation and use
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
ATE337336T1 (de) Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
EA200600738A1 (ru) Способ
CA2071211A1 (en) Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
EP1358318B8 (en) Hybridoma cell line g250 and its use for producing monoclonal antibodies
DE69533504D1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
ATE315649T1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
WO2000045839A3 (en) A method for selecting and producing vaccine and diagnostic preparations
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
WO2002059309A3 (en) Anthozoa derived chromoproteins, fluorescent mutants thereof and methods for using the same
WO2002061389A3 (en) Methods to generate and identify monoclonal antibodies to a large number of human antigens
ATE398678T1 (de) Fusionsprotein zur gleichzeitigen erkennung von humanen autoantikörpern